Medicine Overview

Indication

Know Medicine, Follow Guideline

Adult Dose

Clinical InformationAdministration Information
Indication: Chronic hepatitis B
Age: Adult
Dose: Oral – 300 mg
Frequency: once daily
Indication: HIV infection
Age: Adult
Condition: In combination with other antiretroviral agents
Dose: Oral – 300 mg
Frequency: once daily

Child Dose

Clinical InformationAdministration Information
Indication: HIV Infection
Age: less than 2 years
Dose: Tablet – 300 mg
Note: Safety and efficacy not established
Indication: HIV Infection
Age: greater than 2 years
Dose: Tablet – 8 mg/kg
Frequency: once daily
Note: by mouth (oral); not to exceed 300 mg/day

Renal Dose

Clinical InformationAdministration Information
Condition: Renal impairment: Haemodialysis patients
Dose: 300 mg
Frequency: once every 7 days or after a cumulative total of 12 hours of dialysis
Condition: Renal impairment: Creatinine Clearance 10-29 ml/min
Dose: 300 mg
Frequency: every 72-96 hours
Administration
  • Can be taken with or without food
  • Take at same time daily
Side Effect

Drug Interaction

Drug NameRisk Factors
Atazanavir
Decreased atazanavir concentration unless co-administered with ritonavir
Drugs eliminated by active tubular secretion
Increased serum concentration of tenofovir or co-administered drug

Disease Interaction

Disease NameRisk Factors
Hypersensitivity to Components
Can cause severe allergic reactions

Pregnancy

Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store in a cool and dry place, protected from light and moisture. Keep the medicine out of the reach of children.

Data Sources

Clinical & regulatory information on this page is compiled from the following government sources:

DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.